KR20090102744A - 방사선요법 및 화학요법에 대하여 암세포를 민감하게 하기 위한 표적화 엔비에스1―에이티엠 상호작용 - Google Patents

방사선요법 및 화학요법에 대하여 암세포를 민감하게 하기 위한 표적화 엔비에스1―에이티엠 상호작용

Info

Publication number
KR20090102744A
KR20090102744A KR1020097011353A KR20097011353A KR20090102744A KR 20090102744 A KR20090102744 A KR 20090102744A KR 1020097011353 A KR1020097011353 A KR 1020097011353A KR 20097011353 A KR20097011353 A KR 20097011353A KR 20090102744 A KR20090102744 A KR 20090102744A
Authority
KR
South Korea
Prior art keywords
seq
nbs1
polypeptide
atm
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020097011353A
Other languages
English (en)
Korean (ko)
Inventor
제이. 카리베유 미카엘
보 슈
Original Assignee
써던 리서취 인스티튜트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 써던 리서취 인스티튜트 filed Critical 써던 리서취 인스티튜트
Publication of KR20090102744A publication Critical patent/KR20090102744A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/43—Sweetening agents, e.g. thaumatin, monellin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
KR1020097011353A 2006-10-30 2007-10-30 방사선요법 및 화학요법에 대하여 암세포를 민감하게 하기 위한 표적화 엔비에스1―에이티엠 상호작용 Withdrawn KR20090102744A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86345706P 2006-10-30 2006-10-30
US60/863,457 2006-10-30

Publications (1)

Publication Number Publication Date
KR20090102744A true KR20090102744A (ko) 2009-09-30

Family

ID=39344878

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097011353A Withdrawn KR20090102744A (ko) 2006-10-30 2007-10-30 방사선요법 및 화학요법에 대하여 암세포를 민감하게 하기 위한 표적화 엔비에스1―에이티엠 상호작용

Country Status (9)

Country Link
US (1) US20100120679A1 (cg-RX-API-DMAC7.html)
EP (1) EP2091964A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010508022A (cg-RX-API-DMAC7.html)
KR (1) KR20090102744A (cg-RX-API-DMAC7.html)
CN (1) CN101631799A (cg-RX-API-DMAC7.html)
AU (1) AU2007314366A1 (cg-RX-API-DMAC7.html)
CA (1) CA2674238A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009004748A (cg-RX-API-DMAC7.html)
WO (1) WO2008054726A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101875111B1 (ko) * 2016-04-29 2018-07-09 한국수력원자력 주식회사 저선량 방사선을 이용한 암화유전자 Ras-유도 악성 암화 억제

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8118754B1 (en) 2007-11-15 2012-02-21 Flynn Edward R Magnetic needle biopsy
US9964469B2 (en) 2005-02-28 2018-05-08 Imagion Biosystems, Inc. Magnetic needle separation and optical monitoring
US8841414B1 (en) * 2006-01-27 2014-09-23 University Of Mississippi Medical Center Targeted delivery of therapeutic peptides by thermally responsive biopolymers
US8447379B2 (en) 2006-11-16 2013-05-21 Senior Scientific, LLC Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof
US10194825B2 (en) 2009-11-06 2019-02-05 Imagion Biosystems Inc. Methods and apparatuses for the localization and treatment of disease such as cancer
KR20120087165A (ko) 2009-11-06 2012-08-06 사이언티픽 나노메디슨, 아이엔씨. 표적화된 나노입자 및 그것의 자기 특성을 사용하는 암 및 다른 생물학적 물질과 같은 세포의 검출, 측정 및 이미징
DK2702172T3 (da) * 2011-04-29 2020-04-06 Univ Aarhus Fremgangsmåde til bestemmelse af klinisk relevant hypoxi ved cancer
JP6169607B2 (ja) * 2011-12-27 2017-07-26 ウニヴェルシテ ピエール エ マリー キュリー(パリ 6) 抗腫瘍アジュバント療法
GB201209517D0 (en) * 2012-05-29 2012-07-11 Univ Birmingham Nanoparticles
CN104046644A (zh) * 2013-03-14 2014-09-17 中国科学院上海生命科学研究院 人源化小鼠模型的构建方法和应用
KR101447901B1 (ko) * 2013-04-16 2014-10-16 한양대학교 산학협력단 지방세포 표적 비바이러스성 유전자 전달체
EP3110504B1 (en) * 2014-02-27 2018-12-26 Koninklijke Philips N.V. Medical instrument for high dose rate brachytherapy
WO2017004136A1 (en) 2015-06-30 2017-01-05 Tela Bio, Inc. Corner-lock stitch patterns
US10426587B2 (en) 2015-07-21 2019-10-01 Tela Bio, Inc. Compliance control stitching in substrate materials
US9820843B2 (en) 2016-04-26 2017-11-21 Tela Bio, Inc. Hernia repair grafts having anti-adhesion barriers
BR112019017087A2 (pt) * 2017-02-16 2020-04-14 Firststring Res Inc composição e métodos para prevenir a lesão por radiação e promover a regeneração do tecido.
CA3060510A1 (en) 2017-04-21 2018-10-25 Lunella Biotech, Inc. Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs)
EP3612177A4 (en) 2017-04-21 2021-01-13 Lunella Biotech, Inc. TARGETING HYPOXIC CARCINOUS STEM CELLS (SCC) USING DOXYCYCLINE: IMPLICATIONS FOR IMPROVING ANTI-ANGIOGENIC THERAPY
JP6938682B2 (ja) 2017-05-19 2021-09-22 ルネラ・バイオテック・インコーポレーテッド アンチミトシン:癌幹細胞を根絶するためのミトコンドリア生合成の標的阻害薬
US12006553B2 (en) 2017-05-19 2024-06-11 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
CU20190106A7 (es) 2017-06-26 2020-11-30 Lunella Biotech Inc Mitocetoscinas: agentes terapéuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en células cancerosas
EP3761963B1 (en) 2018-03-09 2025-01-22 Tela Bio, Inc. Surgical repair graft
EP3934575B1 (en) 2019-03-08 2025-05-07 Tela Bio, Inc. Textured medical textiles
WO2023069094A1 (en) * 2021-10-20 2023-04-27 Castor Trevor P Method and apparatus for inactivating pathogens in units of whole blood using superparamagnetic nanoparticles coated with chemiluminescence reagents and broad-spectrum anti-viral therapeutics
CN115300449B (zh) * 2022-02-07 2023-06-27 郑州大学第一附属医院 榄香烯在制备抑制肿瘤耐药性的控释制剂中的应用
CN118126155B (zh) * 2024-02-05 2025-04-25 中山大学附属第七医院(深圳) 一种人nbs1蛋白赖氨酸388位点乳酸化抗原、抗体及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077880A (en) * 1997-08-08 2000-06-20 Cordis Corporation Highly radiopaque polyolefins and method for making the same
US7122343B1 (en) * 1998-04-27 2006-10-17 Wisconsin Alumni Research Foundation Methods to alter levels of a DNA repair protein
US7074902B1 (en) * 1998-04-27 2006-07-11 Warf Wisconsin Alumni Research Foundation Antibody specific for a DNA repair protein
US6530944B2 (en) * 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US20030104427A1 (en) * 2001-06-25 2003-06-05 Petrini John H.J. Methods to modulate telomere structure and function

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101875111B1 (ko) * 2016-04-29 2018-07-09 한국수력원자력 주식회사 저선량 방사선을 이용한 암화유전자 Ras-유도 악성 암화 억제

Also Published As

Publication number Publication date
US20100120679A1 (en) 2010-05-13
AU2007314366A1 (en) 2008-05-08
EP2091964A2 (en) 2009-08-26
WO2008054726A2 (en) 2008-05-08
MX2009004748A (es) 2009-08-25
CN101631799A (zh) 2010-01-20
CA2674238A1 (en) 2008-05-08
WO2008054726A3 (en) 2009-02-05
JP2010508022A (ja) 2010-03-18

Similar Documents

Publication Publication Date Title
US20100120679A1 (en) Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy
EP2250278B1 (en) Methods and compositions related to peptides and proteins with c-terminal elements
EP2951196B1 (en) Cell penetrating peptides for intracellular delivery of molecules
JP7145163B2 (ja) 放射線障害を予防し、組織再生を促進するための組成物および方法
EP2698376B1 (en) Cancer-targeting peptides and uses thereof in cancer therapy
JP2009525055A (ja) 腫瘍および前癌性病変におけるリンパ管のジップコード
KR20120048563A (ko) C?말단 요소를 가진 펩타이드 및 단백질의 사용방법 및 그 조성물
US20160166637A1 (en) Methods of treating a cancer through targeted disruption of alpha connexin 43-zonula occludens-1 (zo-1) interaction
EP1996612A1 (en) Compositions for treatment of cancer
EA022422B1 (ru) Пептидные производные, их получение и применение
JP7072508B2 (ja) 変異型p53と関連している疾患、障害または病状の処置におけるペプチドおよびその使用
EP3545961A1 (en) Novel bsh complex for boron neutron capture therapy
US20230293643A1 (en) Brk peptides and methods of use
US20090233993A1 (en) Compositions and methods for inhibiting gsk3 activity and uses thereof
WO2011133112A1 (en) Cell penetrating peptide derived from the premembrane protein of flavivirus
CA3087744C (en) CYTOCIDAL AGENT
US20110268749A1 (en) Treatment of cancer via targeting of il-13 receptor-alpha2
EP2268664B1 (en) Doc1 compositions and methods for treating cancer
EP3949995B1 (en) Peptide and use thereof
CN109311962A (zh) Bcl-2 l10/ip3受体相互作用的抑制剂

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20090601

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid